Get started
Author

Sofía Rincón-López

Observed names: S. Rincon‐Lopez, Sofia Rincón-López
ORCID: 0009-0009-8972-7006
Observed ORCID: 0009-0009-8972-7006
OpenAlex ID: A5115632004
543 | Obinutuzumab‐induced Adcc as a Predictor of Minimal Residual Disease in Chronic Lymphocytic Leukemia: a Preliminary Study
2025 · R. García‐Muñoz, S. Rincon‐Lopez, et al. · Hematological Oncology · 1
PDF
Immune Effector Cell–associated Hemophagocytic Syndrome (IEC-HS) as a late immune-mediated toxicity after CAR-T therapy in Diffuse Large B-Cell Lymphoma (DLBCL): a case report
2026 · Sofía Rincón-López, Ricardo García-Muñoz, et al. · Annals of Hematology
Predictive value of natural killer (NK) cells in bone marrow for relapse in diffuse large B cell lymphoma: integrating antibody-dependent cell-mediated cytotoxicity (ADCC)-based immunotherapy
2026 · Sofía Rincón-López, Johelys Atencio-Matos, et al. · Cancer Immunology Immunotherapy
PDF
SOX4 in chronic lymphocytic leukaemia: the forgotten transcription factor
2025 · Ricardo García-Muñoz, Jone Alberdi-Ballina, et al. · Blood Research
PDF
510 | the Antibody‐dependent Cellular Cytotoxicity and Metabolic Tumor Volume Balance: a Novel Predictive Marker for Tumor Recurrence in Diffuse Large B‐cell Lymphoma
2025 · S. Rincon‐Lopez, P. Garrastachu‐Zumaran, et al. · Hematological Oncology
PDF
High NK Cell Levels at the End of Obinutuzumab Treatment Are Associated with Negative Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukemia (CLL)
2025 · Ricardo García-Muñoz, Javier Larreina-Pérez, et al. · Research Square
PDF
Mujer de 77 años con lumbalgia, astenia y plaquetopenia
2024 · Ada Esteban-Figuerola, Tamara Zudaire-Fuertes, et al. · Revista Sangre
PDF
Works count: 7
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type